Wasatch Advisors’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
|
|||||
|
2025
Q1 | $10.8M | Buy |
|
|||||
|
2024
Q4 | $21.9M | Buy |
|
|||||
|
2024
Q3 | $32.4M | Buy |
|
|||||
|
2024
Q2 | $22.4M | Buy |
|
|||||
|
2024
Q1 | $35.4M | Sell |
|
|||||
|
2023
Q4 | $40.3M | Buy |
|
|||||
|
2023
Q3 | $11.6M | Sell |
|
|||||
|
2023
Q2 | $19.8M | Buy |
|
|||||
|
2023
Q1 | $17.9M | Sell |
|
|||||
|
2022
Q4 | $34.1M | Sell |
|
|||||
|
2022
Q3 | $52M | Buy |
|
|||||
|
2022
Q2 | $42.7M | Buy |
|
|||||
|
2022
Q1 | $37.3M | Buy |
|
|||||
|
2021
Q4 | $41.7M | Sell |
|
|||||
|
2021
Q3 | $60M | Sell |
|
|||||
|
2021
Q2 | $52.6M | Buy |
|
|||||
|
2021
Q1 | $40.1M | Buy |
|